Supriya Lifesci.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE07RO01027
NSEID: SUPRIYA
BSEID: 543434
View on NSE | View on BSE

INR

577.60

-7.7 (-1.32%)

BSENSE

Mar 13

BSE+NSE Vol: 2.71 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

SMS Pharma.

Senores Pharma.

Innova Captab

Shilpa Medicare

Supriya Lifesci.

Blue Jet Health

Aarti Pharma

FDC

Zota Health Care

SPARC

Sudeep Pharma

Why is Supriya Lifescience Ltd ?

Poor long term growth as Net Sales has grown by an annual rate of 11.47% and Operating profit at 5.52% over the last 5 years

Flat results in Dec 25

With ROE of 18.6, it has a Expensive valuation with a 4.7 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -3.43%, its profits have risen by 6.4% ; the PEG ratio of the company is 3.9

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Supriya Lifesci. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Supriya Lifesci.

-3.43%

-0.09

37.65%

Sensex

1.0%

0.08

12.13%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.47%

EBIT Growth (5y)

5.52%

EBIT to Interest (avg)

81.39

Debt to EBITDA (avg)

0.18

Net Debt to Equity (avg)

-0.07

Sales to Capital Employed (avg)

0.70

Tax Ratio

24.90%

Dividend Payout Ratio

4.28%

Pledged Shares

Institutional Holding

10.21%

ROCE (avg)

28.52%

ROE (avg)

17.74%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.66

EV to EBIT

19.22

EV to EBITDA

17.33

EV to Capital Employed

4.96

EV to Sales

6.22

PEG Ratio

3.93

Dividend Yield

0.17%

ROCE (Latest)

26.04%

ROE (Latest)

18.62%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

NET SALES(Q)

Highest at Rs 206.44 cr

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Supriya Lifesci.

Net Sales - Quarterly

Highest at Rs 206.44 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)